Skip to content

COVID-19 Resources

Access the latest information on COVID-19 for clinical researchers
  • Home
  • About
    • NIH Collaboratory
      • Coordinating Center
      • NIH Collaboratory Trials
      • Core Working Groups
      • Steering Committee
      • Distributed Research Network
      • Our Impact
    • Living Textbook
      • Table of Contents
      • How to Use This Site
  • Resources
    • Data and Resource Sharing
    • Training Resources
    • Tools for Researchers
    • Publications
    • Knowledge Repository
  • Webinar
  • Podcast
  • News
    • News Feed
    • Calendar
    • Subscribe
return to home
Subscribe to Newsletter go to twitter feed go to linkedin go to blue sky feed
Search
NIH Collaboratory
Living Textbook of
Pragmatic Clinical Trials

COVID-19 Resources

Access the latest information on COVID-19 for clinical researchers
home button

Rethinking Clinical Trials

A Living Textbook of Pragmatic Clinical Trials

  • Design
    • What is a Pragmatic Clinical Trial?
    • Decentralized Pragmatic Clinical Trials
    • Developing a Compelling Grant Application
    • Experimental Designs and Randomization Schemes
    • Endpoints and Outcomes
    • Analysis Plan
    • Using Electronic Health Record Data
    • Building Partnerships and Teams to Ensure a Successful Trial
    • Intervention Delivery and Complexity
    • Patient Engagement
  • Data, Tools & Conduct
    • Assessing Feasibility
    • Acquiring Real-World Data
    • Assessing Fitness-for-Use of Real-World Data
    • Study Startup
    • Participant Recruitment
    • Monitoring Intervention Fidelity and Adaptations
    • Patient-Reported Outcomes
    • Clinical Decision Support
    • Mobile Health
    • Electronic Health Records–Based Phenotyping
    • Navigating the Unknown
  • Dissemination & Implementation
    • Data Sharing and Embedded Research
    • Dissemination Approaches for Different Audiences
    • Implementation
    • End-of-Trial Decision-Making
  • Ethics & Regulatory
    • Privacy Considerations
    • Identifying Those Engaged in Research
    • Collateral Findings
    • Consent, Disclosure, and Non-Disclosure
    • Data and Safety Monitoring
    • Ethical Considerations of Data Sharing in Pragmatic Clinical Trials
    • Ethics for AI and ML
    • IRB Responsibilities and Procedures

Introduction

CHAPTER SECTIONS

Analysis Plan


Section 1

Introduction

Expand Contributors

Patrick J. Heagerty, PhD
Elizabeth R. DeLong, PhD
For the NIH Pragmatic Trials Collaboratory Biostatistics and Study Design Core

Contributing Editors
Damon M. Seils, MA
Jonathan McCall, MS

Pragmatic clinical trial designs, particularly those that use cluster randomization or other novel methods, pose challenges during the study design phase (Cook et al 2016). Here, we briefly examine current challenges in the design of pragmatic trials, as well as potential solutions and future directions for further exploration.

Next Section

SECTIONS

CHAPTER SECTIONS

sections

  1. Introduction
  2. Intraclass Correlation
  3. Unequal Cluster Sizes
  4. Accounting for Residual Confounding in the Analysis
  5. Missing Data and Intention-to-Treat Analyses
  6. Electronic Health Record Data Extraction
  7. Unanticipated Changes
  8. Interim Reassessment of Sample Size in Cluster Randomized Trials
  9. Case Study: STOP CRC Trial

REFERENCES

back to top

Cook AJ, Delong E, Murray DM, Vollmer WM, Heagerty PJ. 2016. Statistical lessons learned for designing cluster randomized pragmatic clinical trials from the NIH Health Care Systems Collaboratory Biostatistics and Design Core. Clin Trials. 13:504-512. doi:10.1177/1740774516646578. PMID: 27179253.

back to top


Version History

April 30, 2024: Made nonsubstantive changes to the text as part of the annual content update (changes made D. Seils).

June 23, 2022: Updated the name of the NIH Collaboratory in the contributors list as part of the annual content update (changes made by D. Seils).

May 27, 2020: Added Heagerty to the contributors list and reordered the sections of this chapter as part the annual content update (changes made by D. Seils).

May 1, 2020: Made nonsubstantive formatting changes to the References section as part of the annual content update (changes made by D. Seils).

January 16, 2019: Made nonsubstantive changes to the text as part of the annual content update (changes made by D. Seils).

Published August 25, 2017

current section :

Introduction

  1. Introduction
  2. Intraclass Correlation
  3. Unequal Cluster Sizes
  4. Accounting for Residual Confounding in the Analysis
  5. Missing Data and Intention-to-Treat Analyses
  6. Electronic Health Record Data Extraction
  7. Unanticipated Changes
  8. Interim Reassessment of Sample Size in Cluster Randomized Trials
  9. Case Study: STOP CRC Trial

Citation:

Heagerty PJ, DeLong ER; for the NIH Health Care Systems Research Collaboratory Biostatistics and Study Design Core. Analysis Plan: Introduction. In: Rethinking Clinical Trials: A Living Textbook of Pragmatic Clinical Trials. Bethesda, MD: NIH Pragmatic Trials Collaboratory. Available at: https://rethinkingclinicaltrials.org/chapters/design/analysis-plan-top/analysis-plan-introduction/. Updated October 4, 2024. DOI: 10.28929/015.

Footer Menu

  • How to Use This Site
  • About NIH Collaboratory
  • Enrollment Reporting
  • Grand Rounds
  • Funding Statement
Link to Twitter Link to LinkedIn Link to Blue Sky Link to NIH Collaboratory email

Reference in this Web site to any specific commercial products, process, service, manufacturer, or company does not constitute its endorsement or recommendation by the U.S. Government or National Institutes of Health (NIH). NIH is not responsible for the contents of any “off-site” Web page referenced from this server.

Log in
Privacy Statement
WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly. Site Map